Reliability of Assessing Percentage of Diffusion-Perfusion Mismatch

Background and Purpose— Emergent neurovascular imaging holds promise in identifying new and optimum target populations for thrombolysis in stroke. Recent research has focused on patients with diffusion-weighted MRI (DWI)-perfusion-weighted MRI (PWI) mismatch as a marker of tissue at risk of infarction and a means to select the most suitable candidates for thrombolysis. The present study sought to estimate the reliability of assessing the percentage of DWI-PWI mismatch. Methods— Thirteen patients with acute strokes had DWI and PWI within 7 hours of symptom onset. Six raters independently created relative mean transit time (rMTT) maps and then compared them with DWI images to assess the percentage of mismatch (PWI>DWI) in 10% increments. The MR scans were reassessed by 4 raters, tracing around the lesions to calculate the volume percentage of mismatch. Results— Visual assessment had an interrater reliability of 0.68 (95% CI, 0.52 to 1.0; SEM=21.6%) and an intrarater reliability of 0.80 (95% CI, 0.47 to 1.0; SEM=16.9%). Hand-drawn assessment had an interrater reliability of 0.66 (95% CI, 0.45 to 1.0; SEM=26.2%) and an intrarater reliability of 0.94 (95% CI, 0.81 to 1.0; SEM=10.9%). Conclusions— Results from the present study suggest that quantifying mismatch by the human eye is reproducible but not reliable among observers. This raises doubts about using mismatch for clinical decision making and clinical trial enrollment.

[1]  B. Rosen,et al.  Microscopic susceptibility variation and transverse relaxation: Theory and experiment , 1994, Magnetic resonance in medicine.

[2]  B R Rosen,et al.  Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. , 1999, Radiology.

[3]  G. Albers,et al.  Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. , 1999, Stroke.

[4]  P. Batchelor,et al.  International Society for Magnetic Resonance in Medicine , 1997 .

[5]  Timothy J Carroll,et al.  Absolute Quantification of Cerebral Blood Flow with Magnetic Resonance, Reproducibility of the Method, and Comparison with H215O Positron Emission Tomography , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  B. Rosen,et al.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.

[7]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[8]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[9]  S. Warach.  Thrombolysis in stroke beyond three hours: Targeting patients with diffusion and perfusion MRI , 2002, Annals of neurology.

[10]  F. Buonanno,et al.  Predicting Tissue Outcome in Acute Human Cerebral Ischemia Using Combined Diffusion- and Perfusion-Weighted MR Imaging , 2001, Stroke.

[11]  F. Ståhlberg,et al.  Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques , 2000, Magnetic resonance in medicine.

[12]  J. M. Ollinger,et al.  Positron Emission Tomography , 2018, Handbook of Small Animal Imaging.

[13]  Automated Three-Dimensional Signature Model for Assessing Brain Injury in Emergent Stroke , 2001, Cerebrovascular Diseases.

[14]  C. Weiller,et al.  Severe ADC Decreases Do Not Predict Irreversible Tissue Damage In Humans , 2002, Stroke.

[15]  Antoine M. Hakim.  Ischemic penumbra , 1998, Neurology.

[16]  R J Seitz,et al.  Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. , 1999, Stroke.

[17]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[18]  A. Demchuk,et al.  Why are stroke patients excluded from TPA therapy? , 2001, Neurology.

[19]  Cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking after acute stroke in pigs: comparison with [(15)O]H(2)O positron emission tomography. , 2000, Stroke.

[20]  G. Cosnard,et al.  Usefulness of Magnetic Resonance-Derived Quantitative Measurements of Cerebral Blood Flow and Volume in Prediction of Infarct Growth in Hyperacute Stroke , 2001, Stroke.

[21]  Jeffry R Alger,et al.  Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue , 2003, Stroke.

[22]  W. Hacke,et al.  Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI , 1999, The Lancet.

[23]  Albert Gjedde,et al.  Cerebral Blood Flow and Blood Volume Measured by Magnetic Resonance Imaging Bolus Tracking After Acute Stroke in Pigs: Comparison With [15O]H2O Positron Emission Tomography , 2000 .

[24]  H. Lutsep,et al.  Clinical utility of diffusion‐weighted magnetic resonance imaging in the assessment of ischemic stroke , 1997, Annals of neurology.

[25]  M. Eliasziw,et al.  Statistical methodology for the concurrent assessment of interrater and intrarater reliability: using goniometric measurements as an example. , 1994, Physical therapy.

[26]  J T Kuikka,et al.  Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke. Ischemic penumbra predicts infarct growth. , 1999, Stroke.